Ignite Creation Date:
2024-05-06 @ 2:20 PM
Last Modification Date:
2024-10-26 @ 1:29 PM
Study NCT ID:
NCT04283305
Status:
UNKNOWN
Last Update Posted:
2020-02-25
First Post:
2020-02-14
Brief Title:
Virtual Reality Alcohol Avoidance Training
Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Organization:
Universitätsklinikum Hamburg-Eppendorf
Study Overview
Official Title:
A Randomized Controlled Trial of a Virtual Reality Based Approach-avoidance Training Program for Alcohol Use Disorder
Status:
UNKNOWN
Status Verified Date:
2020-02
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The approach-avoidance training program AATP has shown preliminary promise as an add-on to standard treatment for alcohol dependence However knowledge is lacking as to whether the effectiveness of AATP can be enhanced further when performed in a typical drinking situation The main aim of this study is to investigate whether approach-avoidance training implemented in a virtual reality bar environment is superior to the classical joystick PC-version of the AATP
Detailed Description:
The study will be implemented as a randomized controlled trial A total of 135 consecutively enrolled alcohol use disorder AUD patients recruited from alcohol inpatient clinics in Germany Poland and Denmark will be randomized into one of three groups at the start of standard alcohol treatment group A stimuli-relevant AATP as usual group B stimuli-relevant ATTP in virtual reality and group C treatment as usual TAU control group Treatment outcomes will be assessed at pre-treatment post-treatment and 3-month follow-up Generalized mixed-models will be applied to compare the trajectories of the groups over time on drinking craving and impulsiveness outcomes
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None